NIH funds research on pan-coronavirus vaccines
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today awarded grants to Brigham and Women’s Hospital and two universities to research and develop vaccine candidates that provide broad protective immunity to multiple coronavirus strains.
“These new awards are designed to look ahead and prepare for the next generation of coronaviruses with pandemic potential,” said NIAID Director Anthony Fauci, M.D.
The Pan-Coronavirus Vaccine Development Program expects to award additional grants to projects in 2022.
Related News Articles
Headline
The AHA’s Next Generation Leaders Fellowship today announced its 46 fellows for the class of 2027, who will each work with mentors addressing a…
Headline
The AHA announced July 8 that Erie County Medical Center of Buffalo, N.Y., and the Geriatrics and Extended Care Hospice and Palliative Medicine Team of Orlando…
Headline
Sky Lakes Medical Center, a 176-bed standalone community hospital in Klamath Falls, Ore., is the 2026 winner of the AHA’s Foster G. McGaw Prize for Excellence…
Headline
The Department of Health and Human Services June 30 announced it will terminate emergency use authorization declarations for certain drugs and medical devices…
Headline
Applications for the 2027 AHA Circle of Life Award are due by 1 p.m. ET on July 15. The award celebrates innovative organizations that provide direct patient…
Headline
The Health Resources and Services Administration Maternal and Child Health Bureau has announced grant opportunities available supporting maternal and child…